Decreased right as well as left ventricular function can be associated with pulmonary hypertension (PH). Numerous investigations have examined cardiac function following induction of pulmonary hypertension with monocrotaline (MCT) assuming that MCT has no direct cardiac effect. We tested this assumption by examining left ventricular function and histology of isolated and perfused hearts from MCT-treated rats. Experiments were performed on 50 male Sprague-Dawley rats (348±6 (SD)). Thirty-seven rats received MCT (50 mg/kg s.c.) (MCT group) while the remainder did not (Control group). Three weeks later pulmonary artery pressure was assessed echocardiographically in 20 MCT and 8 Control rats. The hearts were then excised and perfused in the constant pressure Langendorff mode to determine peak left ventricular pressure (LVP), the peak instantaneous rate of pressure increase (+dP/dt max ) and decrease (-dP/dt max ), as well as the rate pressure product (RPP). Histological sections were subsequently examined. 
INTRODUCTION
Pulmonary hypertension represents a serious clinical situation that can occur either as a primary process or secondary to a variety of diseases, conditions and agents (39). Regardless of etiology, all cases of pulmonary hypertension exhibit similar structural vascular remodeling resulting in elevated pulmonary vascular resistance (55) .
An important aspect of the management of patients with pulmonary hypertension concerns the effects of pulmonary hypertension on cardiac function. Right ventricular dysfunction in the setting of chronic pulmonary hypertension has been well described both clinically and experimentally (8, 33, 48) . Decreases in left ventricular systolic and diastolic function have also been reported with pulmonary hypertension (2, 15, 37, 43) . Monocrotaline, derived from the plant Crotalaria spectabilis, has been used extensively to produce pulmonary hypertension in rats (51) . Monocrotaline is a pyrrolizidine alkaloid that is known to be pneumotoxic as well as hepatotoxic in It has been generally assumed that MCT has no effect on the myocardium or coronary vessels per se. Of interest in this regard is seldom-cited older work describing myocarditis and diffuse coronary artery changes following MCT administration in rats (3, 7) . There is limited contemporary data on the direct cardiac effects of MCT. For this purpose, we have assessed the left ventricular systolic function and diastolic relaxation in MCT-treated rats in the isolated perfused heart preparation. In addition we have
Page 5 of 44
conducted histological studies of the ventricular myocardium and intra-mural coronary arteries. Our findings indicate that there are direct deleterious cardiac effects of MCT. 7 echocardiographic interrogation in the pulmonary artery with two-dimensional guidance using a commercially available echocardiography machine (Acuson 128XP) and a 7.5
MHz short focus, phased-array transducer. Pulmonary artery acceleration time (AT) was measured from the onset to the peak velocity of forward systolic pulmonary artery flow.
Peak systolic pulmonary artery pressure (PAP) was calculated using the equation: PAP=137.2-3.3(AT) (30) .
Isolated heart perfusion:
The hearts of the 28 animals studied echocardiographically and those of the 12 rats treated with MCT 7 days earlier were isolated and perfused in the constant pressure Langendorff mode. The rats were anesthetized (total pentobarbital dose 50 mg/kg i.p.), their hearts exposed, chilled with cold saline, and cannulated in situ by way of the aorta.
In the rats studied echocardiographically this was done immediately following pulmonary artery pressure determination. The hearts were perfused at a constant pressure of 100 cm H 2 O with modified Krebs-Ringer buffer at 37°C consisting (in mM) of 119 NaCl, 4.8 KCl, 1.3 CaCl 2 , 1.2 KH 2 PO 4 , 1.2 MgSO 4 , 25 NaHCO 3 as well as 15 glucose maintained at 37°C and aerated with 95% O 2 + 5% CO 2 . Retrograde aortic flow was measured using an ultrasonic flow probe (Transonic). Electrocardiographic recordings were made from three fine needle electrodes inserted into the right ventricle and atria (Powerlab). A small balloon was inserted in the left ventricle by way of the mitral valve.
This balloon was connected to a pressure transducer and its volume adjusted to achieve a diastolic pressure of 10 mmHg at the beginning of the experiment and the volume kept constant for the duration of the study. The natural resonant frequency (48 Hz) and the damping ratio (0.12) of our pressure recording system were determined (22) and found to be within the range required for accurate measurement of left ventricular pressure and its first derivative using fluid filled catheters (18) . The pressure signal, retrograde aortic flow signal and electrocardiogram were recorded digitally using Powerlab instrumentation and software. Following ten minutes of stabilization heart rate (HR), peak left ventricular pressure (LVP), the maximum rate of pressure increase (+dP/dt max ), the maximum rate of pressure decrease (-dP/dt max ), and the rate-pressure product (RPP; RPP=HR•LVP) were determined over five cardiac cycles. Completion of the entire procedure required no more than 15 minutes.
Histology:
Following the isolated heart perfusion experiments the hearts were placed in 10% buffered formalin. Ten days later the hearts were transversally sectioned at the mid-level of the LV papillary muscles. Sixteen 5µm thick sections per heart were stained with Hematoxylin and Eosin (H&E) or Mason's trichrome stain. The right ventricular free wall, interventricular septum and left ventricular posterior wall were examined by light microscopy on the H&E slides for myocytes, interstitium, intra-mural coronary arteries and ventricular wall thickness. Intramural coronary artery area (Aa), lumen area (La), wall area (Wa), and arteriolar wall thickness (Wt) were measured in 5 coronary arterioles of the right ventricular free wall, interventricular septum and left ventricular free wall respectively per section from digitized images using ImageJ software (1). Mason's trichrome stained slides were used to evaluate the extent of collagen deposition. The 9 hearts of 5 control and 5 rats treated with MCT 21 days earlier which did not undergo isolated heart perfusion were also fixed, stained and examined as described above.
Statistical analysis:
All data are expressed as mean ± SD. Comparison of mean values between the groups was performed using an independent t-test. Correlations were analyzed using Pearson's correlation coefficient. The null hypothesis of no effect was rejected at P < 0.05.
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RESULTS:
Clinical observations:
Monocrotaline-treated rats showed significantly less weight gain than the Control group over a period of 21 days (51±10 g vs. 90±8 g). None of the animals showed signs of illness related to right heart failure such as dyspnea or peripheral edema and none exhibited ascites on direct examination of the abdominal cavity at the time of cardiac excision. There was no mortality in either group.
Pulmonary artery pressure:
Monocrotaline administration caused pulmonary hypertension. Pulmonary arterial systolic pressure estimated from AT (see METHODS) was significantly higher in the MCT treated group compared to the Control group (12.9±6 vs. 51±35.3 mmHg (P<0.01)) (see Figure 1) . In 7/20 of the MCT group pulmonary arterial pressure was less than 20 mmHg (10±7), in 5/20 pulmonary arterial pressure was greater than 20 mmHg and less than 60 mmHg (47±7), while in 8/20 pulmonary arterial pressure was greater than 60 mmHg (89±9).
Isolated heart perfusion:
The hearts of 17/20 MCT treated and 8/8 control rats that underwent echocardiography were successfully excised and perfused. We were unable to obtain perfusion data in one animal with PAP less than 20 mmHg , one animal with PAP between 20-60 mmHg, and one animal with PAP greater than 60 mmHg. There was no difference in heart rate between the MCT and Control groups (298±37 vs. 295±21 Myocytes in and around these foci showed degenerative changes, fragmentation, coagulative myocytolysis and necrosis. There was no fibrosis or collagen deposition in these foci. In some hearts, there were small areas of hemorrhage separate from these necrotic sites. In 3 rats, we found features of subendocardial necrosis, coagulative myocytolysis with well-developed fibrosis and extensive collagen deposition in the left ventricular free wall and left ventricular papillary muscles. There was no correlation between the extent or severity of inflammatory infiltration, necrosis, myocytolysis or fibrosis and the severity of pulmonary hypertension or right ventricular free wall thickness.
Intramural coronary arterioles:
The coronary vessels of the Control group appeared normal. However, in the MCT treated rats a diffuse intramural coronary arteriolar medial thickening and decreased coronary arteriolar luminal area were seen throughout the left ventricular posterior wall, inter-ventricular septum and right ventricular free wall ( Figure   5 ). The external diameter of the intramural coronary arteries and their overall area were similar in the Control group and MCT group. However, the internal diameter in the MCT group was significantly less than in the Control group. Both arterial wall thickness and area in the MCT group were significantly greater than that in the Control group and the Page 13 of 44 luminal area in the MCT group was markedly less than in the Control group (see Table   1 ). Examination of the media of the intramural coronary arteries revealed enlarged and hypertrophied smooth muscle cells. The nuclei of these cells were large with 1-2 nucleoli and extended far into the intima sometimes extending all the way to the adventitia. In some cases there was extensive disarray of the smooth muscle cells in the media with intercellular fibrosis and collagen deposition. Similar changes were seen in small conductive arteries (larger than 0.170 mm). There was no correlation between these changes and severity of pulmonary hypertension or right ventricular free wall thickness.
Histology without prior isolated heart perfusion: Histological examination of the hearts of 5 MCT treated rats that did not undergo isolated perfusion revealed the same inflammatory and degenerative myocardial changes as well as medial arteriolar thickening as described above without widening and distension of the interstitial space.
The myocardium and coronary vessels of 5 control hearts that did not undergo isolated perfusion were normal.
Left ventricular performance and histology 7 days after MCT administration:
Similar changes in left ventricular function and myocardial histology were seen in the hearts of the 12 rats treated with MCT 7 days earlier compared to those treated 21 days earlier. Of note is that previous work has shown that pulmonary artery pressure does not increase until at least 10 days following MCT administration in the rat (21, 25 administration. An important feature of this angiopathy is medial hypertrophy, hyperplasia and collagen deposition. Of interest is that the increased pulmonary arterial medial wall thickness is not evident in the first week following monocrotaline administration as we have observed here for the coronary arterioles. The precise mechanisms producing these changes are not known.
We have found increased thickness of the right ventricular free wall in rats treated with MCT. This is expected given the pulmonary hypertension produced by such treatment and is consistent with previous investigations (50) . In addition we have found In conclusion, we have found an impairment of left ventricular systolic function and diastolic relaxation associated with a diffuse myocarditis as well as coronary arteriolar medial thickening that are independent of the severity of pulmonary hypertension and that likely results from a direct toxic effect of MCT on the myocardium.
Our results call into question the use of the MCT induced pulmonary hypertension model to study the cardiac consequences of pulmonary hypertension. 
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